Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Thomas Gregory Calvin, who serves as the Executive Vice President and Chief Technology Officer at Alexandria Real Estate Equities, Inc. (NASDAQ: ARE), has executed a notable purchase of company shares. On April 30, 2026, Calvin acquired 3,500 shares of common stock at a price point of $41.0 per share. This transaction represents a total investment …
Parex (PARXF) is trading near its 52-week high on improving fundamentals, a sub-8x P/E and a 5.4% yield. With a transformative acquisition reportedly close to completion, the risk/reward favors a long position over the next 45 trading days as the market re-rates. This trade plan pairs an entry near current levels, a disciplined stop and a clear tar…
Recent regulatory filings have disclosed insider transaction activity involving 908 Devices Inc. (NASDAQ:MASS). On May 1, 2026, John Kenneweg, who serves as the Senior Vice President of Sales & Product Marketing for the firm, conducted a series of transactions involving the company's common stock. These movements included both the acquisition o…
International Monetary Fund Managing Director Kristalina Georgieva warned that inflation is already rising and that the global economy could face a substantially worse outcome if the Middle East conflict continues into 2027 and oil climbs to roughly $125 per barrel. She said the IMF's previously outlined mild slowdown scenario is no longer feasible…
A recent SEC Form 4 filing reveals that Roy D. Baynes, a director at Travere Therapeutics, Inc. (NASDAQ:TVTX), completed a significant sale of company shares on May 1, 2026. The transaction, which involved the disposal of 9,750 shares of common stock, was conducted under a Rule 10b5-1(c) trading plan established in late 2025. This activity occurs w…
Tango Therapeutics granted non-qualified stock options and restricted stock units to its CFO and a newly hired employee as inducements under its 2023 Inducement Plan, effective May 1, 2026. The awards have an exercise price set at the closing price on the grant date and vest over three to four years, aligning incentives with continued employment.
Pool Corporation has appointed John B. Watwood as its new President and CEO, effective May 4, 2026, succeeding Peter D. Arvan who is stepping down from his roles. John E. Stokely transitions to Executive Chair. The company remains on track with its full-year 2026 financial guidance and postpones its Investor Day event to a later date.
U.S. stock averages finished lower on Monday, with the Dow Jones Industrial Average falling 1.13% and declines centered in Basic Materials, Industrials and Financials. The S&P 500 retreated 0.41% and the Nasdaq Composite dipped 0.19%. A mix of outsized winners on the S&P 500 and the Nasdaq contrasted with steep drops among select logistics and reta…
Canada's main equity gauge ended the session lower, with losses concentrated in Consumer Discretionary, Materials and Industrials. Advancers included Bird Construction, Aecon and BlackBerry, while Gildan Activewear, TFI International and AbraSilver were among the largest decliners. Volatility measures and commodity prices moved notably, with oil ri…
Brazil's main stock index, the Bovespa, closed down 0.92% on Monday, pressured by losses in Real Estate, Financials and Basic Materials sectors. Market breadth favored decliners by a wide margin, though individual gainers included Cvc Brasil ON, Prio SA and Minerva SA/Brazil. Commodity price moves and currency shifts were mixed across the session.
Eton Pharmaceuticals, a Nasdaq-listed pharmaceutical company focused on rare diseases, announced it will release its first quarter 2026 financial results on May 14, 2026. The company will host a live conference call and webcast for investors and stakeholders to discuss the results and answer questions. Eton currently markets ten rare disease produc…
Teva Pharmaceutical Industries Ltd. announced that Eric Hughes, EVP of Global R&D and Chief Medical Officer, will present at the BofA Securities Health Care Conference on May 12, 2026. The presentation will discuss company strategies, innovations in pharmaceuticals and provide insights into their product pipeline and market approach.
TOP Financial Group Limited announced it received a Nasdaq notification for failing to maintain the minimum $1.00 bid price for 30 consecutive business days. The company has 180 days to regain compliance or face potential delisting actions, including a possible reverse stock split. The notification does not affect current trading but signals risk i…
Bakkt, Inc., a regulated fintech company specializing in financial infrastructure, plans to release its first quarter 2026 earnings after market close on May 11, 2026. The company will host a conference call to discuss the results and answer investor questions, with a live webcast and related earnings materials accessible on its investor relations …
CVRx, Inc. has enrolled the first patient in its large-scale BENEFIT-HF trial, designed to evaluate the efficacy of its Barostim device in a significantly expanded heart failure population. The landmark randomized trial aims to enroll 2,500 patients across US and Germany centers, assessing all-cause mortality and heart failure decompensation events…
H&R Block announced a quarterly cash dividend of $0.42 per share payable in July 2026, reinforcing its long-standing history of dividend payments. The company has increased its dividend by 110% since 2016 and has returned over $5 billion to shareholders through dividends and share buybacks. H&R Block continues to provide tax preparation services an…
Cabot Corporation's Board of Directors declared a 5% increase in its quarterly dividend to $0.4725 per share, payable June 12, 2026. The raise highlights confidence in the company's strong cash flow, liquidity, and earnings durability, while maintaining investment capacity and a flexible balance sheet.
BioAge Labs, a clinical-stage biopharmaceutical company, will host an R&D Day webcast on May 8, 2026, presenting Phase 1 clinical data and the development rationale for BGE-102, a novel NLRP3 inflammasome inhibitor. The presentation includes insights from leading experts on NLRP3 biology and potential treatments for atherosclerotic cardiovascular d…
Unitil Corporation announced a net income of $33.2 million, or $1.85 EPS, for Q1 2026, reflecting a $5.7 million increase from Q1 2025. Adjusted net income, excluding transaction costs related to recent acquisitions, was $33.8 million or $1.88 EPS. The company experienced higher electric and gas gross margins driven by rate increases, customer grow…
Opus Genetics announced that its investigational gene therapy OPGx-LCA5 for Leber congenital amaurosis type 5 (LCA5), a rare inherited retinal disease, has been accepted into the FDA's Rare Disease Evidence Principles (RDEP) program. This acceptance supports collaboration with the FDA on regulatory strategy and clinical trial design, potentially ac…
Microvast Holdings, Inc., a leading developer of advanced battery technologies for electric vehicles and energy storage, announced it will release its Q1 2026 financial results after market close on May 11, 2026. A webcast and earnings call will follow to discuss business results and outlook. The company highlighted its 19-year legacy and extensive…
CRISPR Therapeutics AG reported its Q1 2026 financial results, highlighting $43 million in CASGEVY sales and ongoing expansion in approved markets. The company is progressing multiple clinical trials across autoimmune diseases, in vivo liver editing, and siRNA programs targeting major cardiovascular and immuno-oncology indications. Cash reserves in…
Cellectis, a clinical-stage biotech company specializing in gene editing and allogeneic CAR T immunotherapies, will report its Q1 2026 financial results on May 11, 2026 after US market close. The company will not host a conference call but remains available for investor inquiries.
Actors Blake Lively and Justin Baldoni have settled the lawsuit Lively filed over the production of the 2024 film "It Ends With Us," the director's production company said. The agreement averts a civil trial that was scheduled for May and would have included testimony from both parties about allegations of sexual misconduct and subsequent countercl…
Senior investors and executives at the Milken Institute Global Conference in Beverly Hills convened to assess geopolitical tensions, the expanding role of private credit, large-scale sovereign capital deployment and differing views on how artificial intelligence will affect productivity and labor. Speakers outlined how private capital is altering t…
